Trends in mRNA Vaccine Research
Trends in Drug Discovery (Band Nr. 1)
1. Auflage Februar 2025
432 Seiten, Hardcover
32 Abbildungen (31 Farbabbildungen)
Handbuch/Nachschlagewerk
Kurzbeschreibung
The professional guide to the successful development and regulatory approval of mRNA-based vaccines - from the pioneers that brought the first Covid 19 vaccine to market.
Jetzt kaufen
Preis: 159,00 €
Preis inkl. MwSt, zzgl. Versand
Euro-Preise für Wiley-VCH- und Ernst & Sohn-Titel sind nur für Deutschland gültig. In EU-Ländern gilt die lokale Mehrwertsteuer. Portokosten werden berechnet.
Weitere Versionen
The authoritative guide to the revolutionary concept behind the successful Covid-19 vaccines
In 'Trends in mRNA Vaccine Research', a team of distinguished researchers delivers a practical and up-to-date discussion of the biochemical and biomedical foundations of mRNA vaccines. They also explore the manufacturing conditions required for successful vaccine development and review recent progress in a variety of medical fields, including vaccines against pathogens like SARS-CoV-2, HIV, Plasmodium, Mycobacterium tuberculosis, as well as anticancer vaccines.
Volume highlights include:
- A historical overview of mRNA vaccine development
- Immune responses to modified or unmodified mRNA vaccines
- A description of the different mRNA vaccine platforms
- Latest data on current mRNA vaccine developments against infectious diseases and cancer
Perfect for medicinal chemists, immunologists, and epidemiologists, 'Trends in mRNA Vaccine Research' will also benefit researchers and scientists working in the pharmaceutical industry, as well as cancer researchers with an interest in vaccine development.
A Historical Overview on mRNA Vaccine Development
Immune Responses to mRNA Vaccines
Modified or Unmodified mRNA Vaccines? - The Biochemistry of Pseudouridine in mRNA Vaccines
Self-replicating RNA Viruses for Vaccine Development
Circular RNA Therapeutics and Vaccines
GMP and Up-scaling of mRNA Vaccine Production
mRNA Vaccination for Induction of Immune Tolerance Against Autoimmune Disease
PART II: RECENT PROGRESS IN VACCINE RESEARCH AND DEVELOPMENT
Approved mRNA Vaccines Against SARS-CoV-2
mRNA Vaccines for HIV-1
mRNA Vaccines Against Tick-borne Diseases
mRNA Vaccines for Malaria and Other Parasitic Pathogens
mRNA Vaccines Against Mycobacterium tuberculosis
Cancer Vaccines Based on mRNA: Hype or Hope?
Norbert Pardi, PhD, is an Assistant Professor at the University of Pennsylvania, USA. His research is focused on the development of mRNA-based therapeutics with a focus on vaccines.
